Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

PHASE4CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

Rivastigmine transdermal patch

Trial Locations (40)

2031

Novartis Investigative Site, Randwick

2077

Novartis Investigative Site, Hornsby

2250

Novartis Investigative Site, East Gosford

Novartis Investigative Site, Gosford

3065

Novartis Investigative Site, Fitzroy

3081

Novartis Investigative Site, Heidelberg

3353

Novartis Investigative Site, Ballarat

4032

Novartis Investigative Site, Chemside

5000

Novartis Investigative Site, Adelaide

5011

Novartis Investigative Site, Woodville

10330

Novartis Investigative Site, Bangkok

10400

Novartis Investigative Site, Bangkok

10700

Novartis Investigative Site, Bangkok

16059

Novartis Investigative Site, Bursa

26480

Novartis Investigative Site, Meselik / Eskisehir

30990

Novartis Investigative Site, Ipoh

33079

Novartis Investigative Site, Mersin

34093

Novartis Investigative Site, Istanbul

34303

Novartis Investigative Site, Istanbul

34662

Novartis Investigative Site, Altunizade

34668

Novartis Investigative Site, Uskudar / Istanbul

35040

Novartis Investigative Site, Izmir

35340

Novartis Investigative Site, Izmir

38039

Novartis Investigative Site, Talas / Kayseri

41380

Novartis Investigative Site, Kocaeli

42080

Novartis Investigative Site, Konya

50586

Novartis Investigative Site, Kuala Lumpur

55139

Novartis Investigative Site, Atakum / Samsun

59100

Novartis Investigative Site, Kuala Lumpur

70300

Novartis Investigative Site, Seremban

81100

Novartis Investigative Site, Johor Bahru

WA 6009

Novartis Investigative Site, Nedlands

110 744

Novartis Investigative Site, Seoul

463-707

Novartis Investigative Site, Bundang

143-729

Novartis Investigative Site, Seoul

06100

Novartis Investigative Site, Ankara

06500

Novartis Investigative Site, Ankara

07070

Novartis Investigative Site, Antalya

06510

Novartis Investigative Site, Emek / Ankara

06018

Novartis Investigative Site, Etlik / Ankara

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY